Award of liberating technologies, INC. DHA 16.c sttr phase II medical r & d contract from proposal H2-0308 for "no power bionic lower extremity prostheses"

Ended Definitive Contract Awarded Last action

Contract number
W81XWH19C0031
Awardee
Awarding agency
Obligated
$999,080

Award facts

Opportunity
  • HQ003418RCCDT Solicitation number
Contract value 100% obligated
$999,079.52 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Defense Health Agency Department of Defense
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 7 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Holliston, MA 01746, USA
Research
STTR Phase II
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00004 · DHA 16.c sttr phase II medical r & d contract for project titled, "no power bionic lower extremity prostheses" $0
Supplemental Agreement for work within scope P00003 · Medical research and development DHA 16.c sttr phase II H2-12 month no cost extension $0
Supplemental Agreement for work within scope P00002 · DHA 16.c sttr phase II H2-year 1- modification for section 889 $0
Funding Only Action P00001 · Medical research and development DHA 16.c sttr phase II topic number DHA16C-007 no power bionic lower extremity prostheses $476,992
Original award $522,088

About this award

This is a definitive contract awarded by the Defense Health Agency (DHA) to Liberating Technologies Inc. (LTI), a small business, for a Small Business Technology Transfer (STTR) Phase II contract for "No Power Bionic Lower Extremity Prostheses" research and development. The $999,079.52 fixed-price contract has a period of performance through July 10, 2023. As part of the effort, LTI has subcontracted with the Rehabilitation Biomechanics Laboratory at the University of Michigan to design test protocols and test the functionality of the prosthetic foot designs. This contract supports DHA's research and development of advanced prosthetic technologies to improve outcomes and accessibility for individuals with limb loss or impairment.

Quick answers

Who was awarded contract W81XWH19C0031?

W81XWH19C0031 was awarded to Liberating Technologies Inc. by Medical Command (Department of the Army) on February 11, 2019.

How much is contract W81XWH19C0031 worth?

The government has obligated $999,080 on W81XWH19C0031.

Which agency awarded contract W81XWH19C0031?

Medical Command (Department of the Army) awarded W81XWH19C0031, with funding from Defense Health Agency (Department of Defense).

Was contract W81XWH19C0031 competed?

The extent of competition for W81XWH19C0031 was full and open competition after exclusion of sources. The government received 7 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award